BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 29234153)

  • 41. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma.
    Han Y; Tian H; Chen P; Lin Q
    Oncotarget; 2017 Apr; 8(14):22730-22740. PubMed ID: 28186994
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MiR-150 promotes cellular metastasis in non-small cell lung cancer by targeting FOXO4.
    Li H; Ouyang R; Wang Z; Zhou W; Chen H; Jiang Y; Zhang Y; Li H; Liao M; Wang W; Ye M; Ding Z; Feng X; Liu J; Zhang B
    Sci Rep; 2016 Dec; 6():39001. PubMed ID: 27976702
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Knockdown of 14-3-3γ Suppresses Epithelial-Mesenchymal Transition and Reduces Metastatic Potential of Human Non-small Cell Lung Cancer Cells.
    Raungrut P; Wongkotsila A; Champoochana N; Lirdprapamongkol K; Svasti J; Thongsuksai P
    Anticancer Res; 2018 Jun; 38(6):3507-3514. PubMed ID: 29848704
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuropilin 1 expression correlates with the Radio-resistance of human non-small-cell lung cancer cells.
    Dong JC; Gao H; Zuo SY; Zhang HQ; Zhao G; Sun SL; Han HL; Jin LL; Shao LH; Wei W; Jin SZ
    J Cell Mol Med; 2015 Sep; 19(9):2286-95. PubMed ID: 26147006
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overexpression of miR-1290 contributes to cell proliferation and invasion of non small cell lung cancer by targeting interferon regulatory factor 2.
    Jin JJ; Liu YH; Si JM; Ni R; Wang J
    Int J Biochem Cell Biol; 2018 Feb; 95():113-120. PubMed ID: 29275213
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ginkgolic Acid Inhibits Invasion and Migration and TGF-β-Induced EMT of Lung Cancer Cells Through PI3K/Akt/mTOR Inactivation.
    Baek SH; Ko JH; Lee JH; Kim C; Lee H; Nam D; Lee J; Lee SG; Yang WM; Um JY; Sethi G; Ahn KS
    J Cell Physiol; 2017 Feb; 232(2):346-354. PubMed ID: 27177359
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ZEB2 promotes vasculogenic mimicry by TGF-β1 induced epithelial-to-mesenchymal transition in hepatocellular carcinoma.
    Yang Z; Sun B; Li Y; Zhao X; Zhao X; Gu Q; An J; Dong X; Liu F; Wang Y
    Exp Mol Pathol; 2015 Jun; 98(3):352-9. PubMed ID: 25818166
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RCCD1 depletion attenuates TGF-β-induced EMT and cell migration by stabilizing cytoskeletal microtubules in NSCLC cells.
    Wu J; He Z; Yang XM; Li KL; Wang DL; Sun FL
    Cancer Lett; 2017 Aug; 400():18-29. PubMed ID: 28455245
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Γ-Ionizing radiation-induced activation of the EGFR-p38/ERK-STAT3/CREB-1-EMT pathway promotes the migration/invasion of non-small cell lung cancer cells and is inhibited by podophyllotoxin acetate.
    Cho JH; Hong WG; Jung YJ; Lee J; Lee E; Hwang SG; Um HD; Park JK
    Tumour Biol; 2016 Jun; 37(6):7315-25. PubMed ID: 26671552
    [TBL] [Abstract][Full Text] [Related]  

  • 50. YKL-40 regulated epithelial-mesenchymal transition and migration/invasion enhancement in non-small cell lung cancer.
    Jefri M; Huang YN; Huang WC; Tai CS; Chen WL
    BMC Cancer; 2015 Aug; 15():590. PubMed ID: 26275425
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Subpopulations of uPAR+ contribute to vasculogenic mimicry and metastasis in large cell lung cancer.
    Li Y; Sun B; Zhao X; Zhang D; Wang X; Zhu D; Yang Z; Qiu Z; Ban X
    Exp Mol Pathol; 2015 Apr; 98(2):136-44. PubMed ID: 25661888
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of netrin-1 by hypoxia contributes to the invasion and migration of prostate carcinoma cells by regulating YAP activity.
    Chen H; Chen Q; Luo Q
    Exp Cell Res; 2016 Dec; 349(2):302-309. PubMed ID: 27815019
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Netrin‑1 interference potentiates epithelial‑to‑mesenchymal transition through the PI3K/AKT pathway under the hypoxic microenvironment conditions of non‑small cell lung cancer.
    Jin X; Luan H; Chai H; Yan L; Zhang J; Wang Q; Cao L
    Int J Oncol; 2019 Apr; 54(4):1457-1465. PubMed ID: 30968155
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biomarker discovery in highly invasive lung cancer cell through proteomics approaches.
    Kuo CH; Lin MW; Hsu YW; Chou HC; Lin LH; Law CH; Lin YC; Hu RY; Kuo WH; Ko ML; Chang SJ; Lee YR; Chan HL
    Cell Biochem Funct; 2021 Apr; 39(3):367-379. PubMed ID: 33135206
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ubiquitin-specific protease 22 is critical to in vivo angiogenesis, growth and metastasis of non-small cell lung cancer.
    Zhang K; Yang L; Wang J; Sun T; Guo Y; Nelson R; Tong TR; Pangeni R; Salgia R; Raz DJ
    Cell Commun Signal; 2019 Dec; 17(1):167. PubMed ID: 31842906
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-132 inhibits migration, invasion and epithelial-mesenchymal transition by regulating TGFβ1/Smad2 in human non-small cell lung cancer.
    Zhang JX; Zhai JF; Yang XT; Wang J
    Eur Rev Med Pharmacol Sci; 2016 Sep; 20(18):3793-3801. PubMed ID: 27735039
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Knockdown of TRIM66 inhibits malignant behavior and epithelial-mesenchymal transition in non-small cell lung cancer.
    Dai HY; Ma Y; Da Z; Hou XM
    Pathol Res Pract; 2018 Aug; 214(8):1130-1135. PubMed ID: 29929749
    [TBL] [Abstract][Full Text] [Related]  

  • 58. miR‑181b‑5p mediates TGF‑β1-induced epithelial-to-mesenchymal transition in non-small cell lung cancer stem-like cells derived from lung adenocarcinoma A549 cells.
    Li X; Han J; Zhu H; Peng L; Chen Z
    Int J Oncol; 2017 Jul; 51(1):158-168. PubMed ID: 28534939
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TRIM44 promotes proliferation and metastasis in non‑small cell lung cancer via mTOR signaling pathway.
    Xing Y; Meng Q; Chen X; Zhao Y; Liu W; Hu J; Xue F; Wang X; Cai L
    Oncotarget; 2016 May; 7(21):30479-91. PubMed ID: 27058415
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adiponectin inhibits migration and invasion by reversing epithelial‑mesenchymal transition in non‑small cell lung carcinoma.
    Cui E; Guo H; Shen M; Yu H; Gu D; Mao W; Wang X
    Oncol Rep; 2018 Sep; 40(3):1330-1338. PubMed ID: 29956809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.